Arrowhead Pharmaceuticals, Inc.

Schonfeld Strategic Advisors LLC ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

20,105

Value ($000)

1,335

Weight

0.0%

2020 Q3 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,335	0.0%	20,105	12/31/2025
2025 Q3	11/14/2025	18,760	0.1%	543,916	9/30/2025
2025 Q1	5/15/2025	670	0.0%	52,620	3/31/2025
2024 Q4	2/14/2025	11,886	0.1%	632,214	12/31/2024
2024 Q3	11/14/2024	7,509	0.1%	387,687	9/30/2024
2024 Q2	8/14/2024	10,666	0.1%	410,406	6/30/2024
2024 Q1	5/15/2024	11,891	0.1%	415,783	3/31/2024
2023 Q4	2/14/2024	14,084	0.1%	460,277	12/31/2023
2023 Q2	8/14/2023	800	0.0%	22,444	6/30/2023
2022 Q4	2/14/2023	702	0.0%	17,300	12/31/2022
2022 Q3	11/14/2022	1,502	0.0%	45,422	9/30/2022
2022 Q2	8/15/2022	365	0.0%	10,361	6/30/2022
2022 Q1	5/16/2022	809	0.0%	17,600	3/31/2022
2021 Q4	2/14/2022	1,246	0.0%	18,787	12/31/2021
2021 Q2	11/16/2021	1,573	0.0%	18,996	6/30/2021
2021 Q1	5/17/2021	252	0.0%	3,801	3/31/2021
2020 Q4	2/16/2021	1,176	0.0%	15,321	12/31/2020
2020 Q3	11/19/2020	1,346	0.0%	31,251	9/30/2020